NCT04961632 2024-02-01
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
National Cancer Centre, Singapore
Phase 1 Unknown
National Cancer Centre, Singapore
TYK Medicines, Inc
University of Nottingham